sm29
Recombinant proteinexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 17, 2019 (NCT06000514)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Schistosoma mansoniImmunity, active
Schistosoma mansoni immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06000514 | Phase 1/Phase 2 (Phase 2) | Jan 17, 2019 | Conselho Nacional de Desenvolvimento Científico e Tecnológico, Federal University of Bahia, Federal University of Minas Gerais, Oswaldo Cruz Foundation |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | Government | 1 | 0 | 1 | 2019 |
| Federal University of Bahia | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Federal University of Minas Gerais | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Oswaldo Cruz Foundation | Academic/Hospital | 1 | 0 | 1 | 2019 |
4 organizations
Page 1 / 1